WILLIAMS HEMATOLOGY This title has been archived.
Author: Marshall Lichtman, M.D., Thomas Kipps, M.D., Ph.D., Kenneth Kaushansky, M.D., Ernest Beutler, M.D., Uri Seligsohn, M.D., Josef Prchal, M.D.
Publisher: McGraw-Hill
Publication Date: 2006
Publisher: McGraw-Hill
Publication Date: 2006
ISBN 10: 0071435913
ISBN 13: 9780071435918
Edition: 7th
ISBN 13: 9780071435918
Edition: 7th
Description:
The gold standard in hematology! New key points boxes and clinical algorithms that outline discrete strategies for diagnosis and treatment for each chapter and will contain Author's Preferred Management Approach to each chapter. The cell by cell approach offers readers thorough explanations and concise organizational structure.
Table of Contents
Front Matter
PART I CLINICAL EVALUATION OF THE PATIENT
PART II GENERAL HEMATOLOGY
- AGING AND HEMATOPOIESIS
- ERYTHROCYTES
- SERUM IRON, IRON-BINDING CAPACITY, AND FERRITIN LEVELS
- SERUM ERYTHROPOIETIN CONCENTRATION
- SERUM VITAMIN B12 AND FOLATE LEVELS
- LEUKOCYTES
- IMMUNOSENESCENCE
- PLATELETS
- PLASMA COAGULATION FACTORS
- ERYTHROCYTE SEDIMENTATION RATE AND C-REACTIVE PROTEIN
- THE INCIDENCE OF CLONAL HEMOPATHIES
- REFERENCES
STRUCTURE OF THE MARROW AND THE HEMATOPOIETIC MICROENVIRONMENT
THE LYMPHOID TISSUES
HEMATOLOGY OF THE NEWBORN
HEMATOLOGY DURING PREGNANCY
HEMATOLOGY IN OLDER PERSONS
PART III MOLECULAR AND CELLULAR HEMATOLOGY
- THE PATTERN OF INHERITANCE
- THE FAMILY HISTORY
- LINKAGE
- MITOCHONDRIAL INHERITANCE
- EPIGENETICS
- DNA AND THE GENETIC CODE
- TRANSCRIPTION
- RNA PROCESSING
- TRANSLATION
- REGULATION
- THE METHODS OF MOLECULAR BIOLOGY
- MUTATIONS
- GENE DUPLICATION
- PSEUDOGENES
- GENOTYPE–PHENOTYPE CORRELATIONS
- GENOMICS AND PROTEOMICS
- REFERENCES
GENETIC PRINCIPLES AND MOLECULAR BIOLOGY
CYTOGENETICS AND GENE REARRANGEMENT
APOPTOSIS
CELL CYCLE REGULATION AND HEMATOLOGIC DISORDERS
SIGNAL TRANSDUCTION PATHWAYS
THE CLUSTER OF DIFFERENTIATION (CD) ANTIGENS
HEMATOPOIETIC STEM CELLS, PROGENITORS, AND CYTOKINES
THE INFLAMMATORY RESPONSE
INNATE IMMUNITY
DENDRITIC CELLS AND THE CONTROL OF INNATE AND ADAPTIVE IMMUNITY
PART IV THERAPEUTIC PRINCIPLES
- HISTORY
- BASIC PRINCIPLES OF CANCER CHEMOTHERAPY
- CELL CYCLE-ACTIVE AGENTS
- ANTITUBULINS
- TOPOISOMERASE I INHIBITORS
- ANTHRACYCLINE ANTIBIOTICS
- TOPOISOMERASE II INHIBITORS
- MOLECULARLY TARGETED SMALL MOLECULES
- AGENTS ACTIVE THROUGHOUT THE CELL CYCLE
- MATURING (TERMINAL DIFFERENTIATING) AGENTS
- THERAPEUTIC MONOCLONAL ANTIBODIES
- REFERENCES
- HISTORY
- STEM CELL MODEL OF HEMATOPOIESIS
- SOURCES OF HEMATOPOIETIC STEM CELLS
- DISEASES TREATED WITH HEMATOPOIETIC CELL TRANSPLANTATION
- CONCEPTS OF CURATIVE THERAPY
- FACTORS INFLUENCING OUTCOME
- COMPLICATIONS OF HEMATOPOIETIC CELL TRANSPLANTATION
- SELECTED RESULTS OF HEMATOPOIETIC CELL TRANSPLANTATION
- FUTURE ROLE OF HEMATOPOIETIC CELL TRANSPLANTATION
- REFERENCES
PHARMACOLOGY AND TOXICITY OF ANTINEOPLASTIC DRUGS
TREATMENT OF INFECTIONS IN THE IMMUNOCOMPROMISED HOST
PRINCIPLES OF ANTITHROMBOTIC THERAPY
PRINCIPLES OF HEMATOPOIETIC CELL TRANSPLANTATION
PRINCIPLES OF IMMUNE CELL THERAPY
PRINCIPLES OF VACCINE THERAPY
PRINCIPLES OF THERAPEUTIC APHERESIS: INDICATIONS, EFFICACY, AND COMPLICATIONS
PRINCIPLES OF GENE TRANSFER FOR THERAPY
PAIN MANAGEMENT
PART V THE ERYTHROCYTE
- EPIDEMIOLOGY
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II (HEMPAS)
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III
- OTHER FORMS OF CONGENITAL DYSERYTHROPOIETIC ANEMIA AND SIMILAR DISORDERS
- ERYTHROCYTE ENZYME ABNORMALITIES IN CONGENITAL DYSERYTHROPOIETIC ANEMIA
- DIFFERENTIAL DIAGNOSIS
- REFERENCES
MORPHOLOGY OF THE ERYTHRON
COMPOSITION OF THE ERYTHROCYTE
PRODUCTION OF ERYTHROCYTES
DESTRUCTION OF ERYTHROCYTES
CLINICAL MANIFESTATIONS AND CLASSIFICATION OF ERYTHROCYTE DISORDERS
APLASTIC ANEMIA
PURE RED CELL APLASIA
ANEMIA OF CHRONIC RENAL FAILURE
ANEMIA OF ENDOCRINE DISORDERS
THE CONGENITAL DYSERYTHROPOIETIC ANEMIAS
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
FOLATE, COBALAMIN, AND MEGALOBLASTIC ANEMIAS
DISORDERS OF IRON METABOLISM
ANEMIA RESULTING FROM OTHER NUTRITIONAL DEFICIENCIES
ANEMIA ASSOCIATED WITH MARROW INFILTRATION
ANEMIA OF CHRONIC DISEASE
DISORDERS OF THE RED BLOOD CELL MEMBRANE: HEREDITARY SPHEROCYTOSIS, ELLIPTOCYTOSIS, AND RELATED DISORDERS
DISORDERS OF RED CELLS RESULTING FROM ENZYME ABNORMALITIES
DISORDERS OF GLOBIN SYNTHESIS: THE THALASSEMIAS
DISORDERS OF HEMOGLOBIN STRUCTURE: SICKLE CELL ANEMIA AND RELATED ABNORMALITIES
METHEMOGLOBINEMIA AND OTHER CAUSES OF CYANOSIS
HEMOLYTIC ANEMIA RESULTING FROM PHYSICAL INJURY TO RED CELLS
HEMOLYTIC ANEMIA RESULTING FROM CHEMICAL AND PHYSICAL AGENTS
HEMOLYTIC ANEMIA RESULTING FROM INFECTIONS WITH MICROORGANISMS
HEMOLYTIC ANEMIA RESULTING FROM IMMUNE INJURY
ALLOIMMUNE HEMOLYTIC DISEASE OF THE NEWBORN
ACUTE BLOOD LOSS ANEMIA
HYPERSPLENISM AND HYPOSPLENISM
PRIMARY AND SECONDARY POLYCYTHEMIAS (ERYTHROCYTOSIS)
THE HEMATOLOGIC ASPECTS OF PORPHYRIA
HEREDITARY AND ACQUIRED SIDEROBLASTIC ANEMIAS
PART VI NEUTROPHILS, EOSINOPHILS, BASOPHILS, AND MAST CELLS
MORPHOLOGY OF NEUTROPHILS, EOSINOPHILS, AND BASOPHILS
COMPOSITION OF NEUTROPHILS
PRODUCTION, DISTRIBUTION, AND FATE OF NEUTROPHILS
EOSINOPHILS AND THEIR DISORDERS
BASOPHILS AND MAST CELLS AND THEIR DISORDERS
CLASSIFICATION AND CLINICAL MANIFESTATIONS OF NEUTROPHIL DISORDERS
NEUTROPENIA AND NEUTROPHILIA
DISORDERS OF NEUTROPHIL FUNCTION
PART VII MONOCYTES AND MACROPHAGES
- IDENTIFICATION AND KINETIC STUDIES OF MONOCYTES AND MACROPHAGES
- PHYLOGENY AND ONTOGENY OF MACROPHAGES
- TISSUE DISTRIBUTION OF MONOCYTES AND MACROPHAGES
- DEVELOPMENT OF MONOCYTES IN THE MARROW
- KINETICS OF MONOCYTES IN CIRCULATION AND IN INFLAMMATORY LESIONS
- DIFFERENTIATION OF MONOCYTES INTO MACROPHAGES
- MULTINUCLEATED GIANT CELLS
- DENDRITIC CELLS AND THEIR RELATIONSHIP TO MONOCYTES AND MACROPHAGES
- FATE OF MONOCYTES AND MACROPHAGES
- REFERENCES
MORPHOLOGY OF MONOCYTES AND MACROPHAGES
BIOCHEMISTRY AND FUNCTION OF MONOCYTES AND MACROPHAGES
PRODUCTION, DISTRIBUTION, AND FATE OF MONOCYTES AND MACROPHAGES
CLASSIFICATION AND CLINICAL MANIFESTATIONS OF DISORDERS OF MONOCYTES AND MACROPHAGES
MONOCYTOSIS AND MONOCYTOPENIA
INFLAMMATORY AND MALIGNANT HISTIOCYTOSIS
LIPID STORAGE DISEASES
PART VIII LYMPHOCYTES AND PLASMA CELLS
MORPHOLOGY OF LYMPHOCYTES AND PLASMA CELLS
COMPOSITION AND BIOCHEMISTRY OF LYMPHOCYTES AND PLASMA CELLS
LYMPHOPOIESIS
FUNCTIONS OF B LYMPHOCYTES AND PLASMA CELLS IN IMMUNOGLOBULIN PRODUCTION
FUNCTIONS OF T LYMPHOCYTES: T CELL RECEPTORS FOR ANTIGEN
FUNCTIONS OF NATURAL KILLER CELLS
CLASSIFICATION AND CLINICAL MANIFESTATIONS OF LYMPHOCYTE AND PLASMA CELL DISORDERS
LYMPHOCYTOSIS AND LYMPHOCYTOPENIA
IMMUNODEFICIENCY DISEASES
HEMATOLOGIC ASPECTS OF HUMAN IMMUNODEFICIENCY SYNDROME
MONONUCLEOSIS SYNDROMES
PART IX MALIGNANT DISEASES
- MINIMAL-DEVIATION MYELOID CLONAL DISORDERS
- MODERATE-DEVIATION CLONAL MYELOID DISORDERS
- MODERATELY SEVERE-DEVIATION CLONAL MYELOID DISORDERS
- SEVERE-DEVIATION CLONAL MYELOID DISORDERS
- TRANSITIONS AMONG CLONAL MYELOID DISEASES
- PATHOGENESIS OF CLONAL MYELOID DISEASES
- PHENOTYPE OF MYELOID CLONAL DISEASES AS A RESULT OF THE MATRIX OF DIFFERENTIATION AND MATURATION
- PLURIPOTENTIAL STEM CELL POOL AS SITE OF THE LESION
- PROGENITOR CELL LEUKEMIA
- QUANTITATIVENESS OF CLONAL MYELOID DISEASES
- INTERPLAY OF CLONAL AND POLYCLONAL HEMATOPOIESIS
- CLINICAL MANIFESTATIONS
- REFERENCES
- DEFINITION
- HISTORY
- CLASSIFICATION
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- CLINICAL FEATURES
- LABORATORY FEATURES
- SPECIFIC MYELODYSPLASTIC SYNDROMES
- TREATMENT OF MDS BASED ON PROGNOSTIC SCORE
- UNCOMMON ACQUIRED SYNDROMES WITH INCREASED RISK OF ACUTE MYELOGENOUS LEUKEMIA
- INDOLENT CLONAL MYELOID DISORDERS OR OLIGOBLASTIC (MYELOGENOUS) LEUKEMIA PRECEDING OR EMERGING IN LYMPHOID MALIGNANCIES OTHER THAN ACUTE LYMPHOCYTIC LEUKEMIA
- REFERENCES
- DEFINITION AND HISTORY
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- CLINICAL FEATURES
- SPECIAL CLINICAL FEATURES
- DIFFERENTIAL DIAGNOSIS
- THERAPY
- COURSE AND PROGNOSIS
- ACCELERATED PHASE AND BLAST CRISIS OF CML
- RELATED CLONAL MYELOID DISEASES WITHOUT THE PH CHROMOSOME (TABLE 88-5)
- PH-CHROMOSOME –POSITIVE ACUTE LEUKEMIA
- REFERENCES
- DEFINITION AND HISTORY
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- EXTRANODAL LYMPHOMA
- DIFFUSE LARGE B CELL LYMPHOMA
- FOLLICULAR LYMPHOMA
- MARGINAL ZONE B CELL LYMPHOMA
- MANTLE CELL LYMPHOMA
- BURKITT LYMPHOMA
- ADULT T CELL LEUKEMIA/LYMPHOMA
- EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA: NASAL TYPE
- ENTEROPATHY-TYPE T CELL LYMPHOMA
- HEPATOSPLENIC T CELL LYMPHOMA
- SUBCUTANEOUS PANNICULITIS-LIKE T CELL LYMPHOMA
- CUTANEOUS T CELL LYMPHOMA (MYCOSIS FUNGOIDES AND SÉZARY SYNDROME)
- PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA
- ANAPLASTIC LARGE CELL LYMPHOMA
- PERIPHERAL T CELL LYMPHOMA, UNSPECIFIED
- ANGIOIMMUNOBLASTIC T CELL LYMPHOMA
- DISORDERS THAT PREDISPOSE TO LYMPHOMA
- NONMALIGNANT DISORDERS OF THE LYMPH NODES THAT MIMIC LYMPHOMA
- REFERENCES
CLASSIFICATION AND CLINICAL MANIFESTATIONS OF THE CLONAL MYELOID DISORDERS
MYELODYSPLASTIC SYNDROMES (CLONAL CYTOPENIAS AND OLIGOBLASTIC LEUKEMIA)
ACUTE MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA AND RELATED DISORDERS
IDIOPATHIC MYELOFIBROSIS (MYELOFIBROSIS WITH MYELOID METAPLASIA)
CLASSIFICATION OF MALIGNANT LYMPHOID DISORDERS
ACUTE LYMPHOBLASTIC LEUKEMIA
CHRONIC LYMPHOCYTIC LEUKEMIA AND RELATED DISEASES
HAIRY CELL LEUKEMIA
LARGE GRANULAR LYMPHOCYTIC LEUKEMIA
PATHOLOGY OF LYMPHOMAS
THE NON-HODGKIN LYMPHOMAS
HODGKIN LYMPHOMA
PLASMA CELL NEOPLASMS: GENERAL CONSIDERATIONS
ESSENTIAL MONOCLONAL GAMMOPATHIES
PLASMA CELL MYELOMA
THE AMYLOIDOSES
MACROGLOBULINEMIA
HEAVY-CHAIN DISEASES
PART X HEMOSTASIS AND THROMBOSIS
- VITAMIN K–DEPENDENT ZYMOGENS (PROTHROMBIN, FACTORS VII, IX, AND X, AND PROTEIN C)
- SOLUBLE COFACTORS (PROTEIN S, FACTORS V AND VIII, AND VON WILLEBRAND FACTOR)
- FACTOR XI AND THE CONTACT FACTORS
- CELL-ASSOCIATED COFACTORS
- FIBRINOGEN
- FACTOR XIII
- THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
- INHIBITORS
- PATHWAYS OF HEMOSTASIS
- REFERENCES
- INTRODUCTION
- BLOOD COAGULATION PATHWAYS AND THE PROTEIN C PATHWAY
- HEREDITARY DEFICIENCIES ASSOCIATED WITH THROMBOTIC DISEASE
- PROTEIN C PATHWAY COMPONENTS
- ACTIVATION OF PROTEIN C
- ACTIVATED PROTEIN C ACTIVITIES
- INHIBITION OF ACTIVATED PROTEIN C
- ACTIVATED PROTEIN C-INDEPENDENT ANTICOAGULANT ACTIVITY OF PROTEIN S
- INHIBITION OF COAGULATION PROTEASES BY PROTEASE INHIBITORS
- MURINE GENE DELETION STUDIES OF ANTICOAGULANT FACTORS
- REFERENCES
- PLATELET KINETICS
- SPURIOUS THROMBOCYTOPENIA (PSEUDOTHROMBOCYTOPENIA)
- THROMBOCYTOPENIA RESULTING FROM IMPAIRED PLATELET PRODUCTION
- ACQUIRED THROMBOCYTOPENIA RESULTING FROM IMPAIRED PLATELET PRODUCTION
- THROMBOCYTOPENIA RESULTING FROM ACCELERATED PLATELET DESTRUCTION
- THROMBOCYTOPENIA DURING PREGNANCY
- ABNORMAL PLATELET DISTRIBUTION OR POOLING
- REFERENCES
- INTRODUCTION
- STRUCTURE AND SYNTHESIS
- FIBRINOGEN CONVERSION TO FIBRIN AND NETWORK ASSEMBLY
- FIBRINOLYSIS
- THROMBIN BINDING TO FIBRINOGEN AND FIBRIN (ANTITHROMBIN I)
- AFIBRINOGENEMIA AND HYPOFIBRINOGENEMIA (ANTITHROMBIN I DEFICIENCY)
- DYSFIBRINOGENEMIA
- HYPODYSFIBRINOGENEMIA
- DYSFIBRINOGENEMIA AND AVASCULAR OSTEONECROSIS
- THROMBOPHILIA RELATED TO DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA
- REFERENCES
- DEFINITION AND HISTORY
- PATHOGENESIS
- EPIDEMIOLOGY
- MAJOR HEREDITARY DEFECTS
- NEW METHODS FOR THROMBOPHILIA DISCOVERY
- INTERACTIONS BETWEEN DIFFERENT THROMBOPHILIAS AND BETWEEN THROMBOPHILIA AND ENVIRONMENTAL FACTORS
- RECURRENT VENOUS THROMBOSIS IN THROMBOPHILIAS
- HEREDITARY THROMBOPHILIAS DURING PREGNANCY AND PUERPERIUM
- DIAGNOSIS
- THERAPY
- PROPHYLAXIS
- REFERENCES
- DEFINITION AND HISTORY
- ETIOLOGY AND PATHOGENESIS
- CLINICAL FEATURES
- LABORATORY FEATURES
- DIFFERENTIAL DIAGNOSIS OF DEEP VEIN THROMBOSIS
- OBJECTIVE TESTING FOR DEEP VEIN THROMBOSIS
- DIFFERENTIAL DIAGNOSIS OF PULMONARY EMBOLISM
- OBJECTIVE TESTING FOR PULMONARY EMBOLISM
- THERAPY, COURSE, AND PROGNOSIS
- REFERENCES
MEGAKARYOPOIESIS AND THROMBOPOIESIS
PLATELET MORPHOLOGY, BIOCHEMISTRY, AND FUNCTION
MOLECULAR BIOLOGY AND BIOCHEMISTRY OF THE COAGULATION FACTORS AND PATHWAYS OF HEMOSTASIS
CONTROL OF COAGULATION REACTIONS
VASCULAR FUNCTION IN HEMOSTASIS
CLASSIFICATION, CLINICAL MANIFESTATIONS, AND EVALUATION OF DISORDERS OF HEMOSTASIS
THROMBOCYTOPENIA
ESSENTIAL THROMBOCYTHEMIA AND THROMBOCYTOSIS
HEREDITARY QUALITATIVE PLATELET DISORDERS
ACQUIRED QUALITATIVE PLATELET DISORDERS
THE VASCULAR PURPURAS
HEMOPHILIA A AND HEMOPHILIA B
INHERITED DEFICIENCIES OF COAGULATION FACTORS II, V, VII, X, XI, AND XIII AND COMBINED DEFICIENCIES OF FACTORS V AND VIII AND OF THE VITAMIN K-DEPENDENT FACTORS
HEREDITARY FIBRINOGEN ABNORMALITIES
VON WILLEBRAND DISEASE
ANTIBODY-MEDIATED COAGULATION FACTOR DEFICIENCIES
HEMOSTATIC DYSFUNCTION RELATED TO LIVER DISEASES AND LIVER TRANSPLANTATION
DISSEMINATED INTRAVASCULAR COAGULATION
HEREDITARY THROMBOPHILIA
THE ANTIPHOSPHOLIPID SYNDROME
ANTIBODY-MEDIATED THROMBOTIC DISORDERS: IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA AND HEPARIN-INDUCED THROMBOCYTOPENIA
VENOUS THROMBOSIS
ATHEROTHROMBOSIS: DISEASE INITIATION, PROGRESSION, AND TREATMENT
FIBRINOLYSIS AND THROMBOLYSIS
PART XI TRANSFUSION MEDICINE
- DEFINITIONS AND HISTORY
- BLOOD GROUP SYSTEMS
- GENERAL IMMUNOLOGY OF BLOOD GROUP ANTIGENS
- ANTIGEN EXPRESSION
- BIOCHEMISTRY OF ERYTHROCYTE ANTIGENS
- EFFECT OF ENZYMES AND OTHER CHEMICALS ON ERYTHROCYTE ANTIGENS
- GENETICS OF ERYTHROCYTE ANTIGENS
- RED CELL ANTIGENS IN HEALTH AND DISEASE
- ASSOCIATIONS OF RED CELL ANTIGENS WITH DISEASE
- ANTIERYTHROCYTE ANTIBODIES
- CLINICAL SIGNIFICANCE OF ERYTHROCYTE ANTIBODIES
- SEROLOGIC DETECTION OF ERYTHROCYTE ANTIGENS AND ANTIBODIES
- REFERENCES
- INTRODUCTION
- TECHNIQUES FOR PLATELET PREPARATION
- STORAGE OF PLATELET CONCENTRATES
- CLINICAL RESPONSE
- THROMBOCYTOPENIA RESULTING FROM PLATELET LOSS, SEQUESTRATION, OR DESTRUCTION
- COMPLICATIONS OF PLATELET TRANSFUSION
- COMPLICATIONS RESULTING FROM CONTAMINATING LEUKOCYTES
- COMPLICATIONS RESULTING FROM CONTAMINATING RED CELLS
- COMPLICATIONS RESULTING FROM PLASMA AND ITS CONTENTS
- COMPLICATIONS RESULTING FROM PLATELETS THEMSELVES
- REFERENCES
ERYTHROCYTE ANTIGENS AND ANTIBODIES
HUMAN LEUKOCYTE AND PLATELET ANTIGENS
BLOOD PROCUREMENT AND SCREENING
PRESERVATION AND CLINICAL USE OF ERYTHROCYTES AND WHOLE BLOOD
PRESERVATION AND CLINICAL USE OF PLATELETS
COLOR PLATES
- PLATE I RED CELL MORPHOLOGY
- PLATE II RED CELL MORPHOLOGY
- PLATE III RED CELL MORPHOLOGY
- PLATE IV RED CELL MORPHOLOGY
- PLATE V NORMAL ERYTHROPOIESIS
- PLATE VI MEGALOBLASTIC ERYTHROPOIESIS
- PLATE VII GRANULOCYTE AND MONOCYTE MORPHOLOGY
- PLATE VIII GRANULOCYTE MORPHOLOGY
- PLATE IX MACROPHAGES
- PLATE X NORMAL NEUTROPHILOPOIESIS
- PLATE XI NORMAL MEGAKARYOCYTOPOIEIS
- PLATE XII ABNORMAL MEGAKARYOCYTOPOIEIS AND PLATELETS
- PLATE XIII NORMAL AND ABNORMAL PLATELETS
- PLATE XIV MARROW SECTIONS
- PLATE XV NON-HEMATOPOIETIC CELLS IN MARROW
- PLATE XVI ACUTE MYELOGENOUS LEUKEMIA
- PLATE XVII ACUTE MYELOGENOUS LEUKEMIA
- PLATE XVIII MYELODYSPLASIA
- PLATE XIX CHRONIC MYELOGENOUS LEUKEMIA
- PLATE XX LYMPHOCYTES AND ACUTE AND CHRONIC LYMPHOCYTIC LEUKEMIA
- PLATE XXI PLASMA CELLS AND MYELOMA
- PLATE XXII LYMPH NODE BIOPSIES
- PLATE XXIII FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR CYTOGENETIC ANALYSIS
- PLATE XXIV PARASITES IN THE BLOOD
- PLATE XXV CUTANEOUS LESIONS
Topics within this title:
- Agammaglobulinemia
- Anemia
- Antibody
- Atherosclerosis
- Chronic Disease
- Cyanosis
- Folic Acid Deficiency
- Hyperplasia
- Infarction
- Leukemia
- Liver Diseases
- Lymphomas
- Methemoglobinemia
- Myocardial Infarction
- Pain
- Polycythemia
- Polycythemia Vera
- Sepsis
- Severe Combined Immunodeficiency
- Signs and Symptoms
- Syndrome
- Thalassemia
- Thrombocytopenia
- Thrombocytosis
- Thrombophilia
- Thrombosis